| Announce Date | 01/27/2026 |
| EPS Normalized Actual | $2.5 (Beat by $0.02) |
| EPS GAAP Actual | $2.5 (Beat by $0.02) |
| Revenue Actual | $1.16302B |
| Revenue Surprise | Beat by $1163.02M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.575 |
| EPS GAAP Estimate | $2.575 |
| Revenue Estimate | $1.21595B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2028 | 12.11 | 24.09 | 11.90941 | 12.30169 | 1 |
| Jun 2027 | 11.2 | 26.05 | 11.04215 | 11.35763 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.54 | 0.195 | 1.16302B | 7.74% | 51.87M |
| FQ3 2025 (Sep 2025) | 2.67 | -0.0575 | 1.19952B | 8.39% | -41.27M |
| FQ2 2025 (Jun 2025) | 2.84 | 2.84 | 1.22473B | 5.23% | 1224.73M |
| FQ1 2025 (Mar 2025) | 2.6 | 0.03 | 1.16675B | 1.75% | -37.95M |
| FQ4 2024 (Dec 2024) | 2.43 | 2.43 | 1.073B | 100% | 1073M |
| FQ3 2024 (Sep 2024) | 2.4 | 2.4 | 1.09894B | 0.34% | 1098.94M |
| FQ2 2024 (Jun 2024) | 2.68 | 2.68 | 1.16067B | 0.22% | 1160.67M |
| FQ1 2024 (Mar 2024) | 2.51 | 2.51 | 1.14639B | 1.25% | 1146.39M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.575
Consensus Revenue Estimates
1.21595B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 3.31 | -- | 3.20878 | 3.35818 | 2 |
| FQ4 2027 (Dec 2027) | 2.99 | -- | 2.89857 | 3.03352 | 1 |
| FQ3 2027 (Sep 2027) | 3.05 | -- | 2.95673 | 3.09439 | 1 |
| FQ1 2027 (Mar 2027) | 3.2 | -- | 3.13402 | 3.35336 | 3 |
| FQ4 2026 (Dec 2026) | 2.85 | 10.88 | 2.79123 | 2.98658 | 3 |
| FQ3 2026 (Sep 2026) | 2.75 | 2.91 | 2.69329 | 2.88179 | 3 |
| FQ1 2026 (Mar 2026) | 2.575 | -0.97 | 2.41835 | 2.67845 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 1.35B | -- | 1.31B | 1.36B | 1 |
| FQ4 2027 (Dec 2027) | 1.27B | -- | 1.24B | 1.28B | 2 |
| FQ3 2027 (Sep 2027) | 1.3B | -- | 1.27B | 1.31B | 2 |
| FQ1 2027 (Mar 2027) | 1.35B | -- | 1.33B | 1.4B | 4 |
| FQ4 2026 (Dec 2026) | 1.33B | 12.27 | 1.3B | 1.37B | 4 |
| FQ3 2026 (Sep 2026) | 1.3B | 7.61 | 1.28B | 1.35B | 4 |
| FQ1 2026 (Mar 2026) | 1.22B | 4.05 | 1.16B | 1.25B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.345 | 2.54 | 0.195 | 7.68% |
| FQ3 2025 (Sep 2025) | 2.7275 | 2.67 | -0.0575 | -2.15% |
| FQ2 2025 (Jun 2025) | 2.84 | 2.84 | 100% | |
| FQ1 2025 (Mar 2025) | 2.57 | 2.6 | 0.03 | 1.15% |
| FQ4 2024 (Dec 2024) | 2.43 | 2.43 | 100% | |
| FQ3 2024 (Sep 2024) | 2.4 | 2.4 | 100% | |
| FQ2 2024 (Jun 2024) | 2.68 | 2.68 | 100% | |
| FQ1 2024 (Mar 2024) | 2.51 | 2.51 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $1.11B | $1.16B | $51.87M | 4.46% |
| FQ3 2025 (Sep 2025) | $1.24B | $1.2B | $-41.27M | -3.44% |
| FQ2 2025 (Jun 2025) | $0B | $1.22B | $1224.73M | 100% |
| FQ1 2025 (Mar 2025) | $1.2B | $1.17B | $-37.95M | -3.25% |
| FQ4 2024 (Dec 2024) | $0B | $1.07B | $1073M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.1B | $1098.94M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.16B | $1160.67M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.15B | $1146.39M | 100% |